0001428336-26-000012
SEC filingHealthEquity appointed William Gassen, CEO of Sanford Health, to its Board of Directors effective March 26, 2026, expanding the Board to ten members and adding him to two key committees.
HealthEquity has strengthened its board with the appointment of William Gassen, the CEO of Sanford Health, a significant customer relationship. The company received $123,923 in revenue from Sanford Health in the fiscal year ended January 31, 2026, and expects to receive over $120,000 in the following fiscal year. Gassen's deep healthcare system leadership experience, particularly in care delivery and financing, is cited as valuable perspective for HealthEquity's consumer-directed benefits business. His immediate assignment to both the Audit and Risk Committee and the Talent, Compensation and Culture Committee indicates he will be involved in critical oversight functions. The appointment follows standard governance procedures with no special arrangements, and he will receive the company's standard non-employee director compensation package.